Halozyme Reports First Quarter 2020 Results

Go back to Halozyme Reports First Quarter 2020 Results
Halozyme Therapeutics, Inc. (NASDAQ: HALO) Delayed: 76.20 -2.42 (3.08%)
Previous Close $78.62    52 Week High $18.39 
Open $78.82    52 Week Low $6.96 
Day High $79.19    P/E N/A 
Day Low $75.33    EPS $-0.58 
Volume 1,474,290